H.R. 7479

119 HR 7479 IH: Workplace Overdose Reversal Kits to Save Lives Act
 U.S. House of Representatives
 2026-02-10
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  2d Session  H. R. 7479  IN THE HOUSE OF REPRESENTATIVES   February 10, 2026   Mrs. Watson Coleman  (for herself,  Mr. Rutherford ,  Ms. Tlaib ,  Mrs. McIver ,  Ms. Craig ,  Ms. Budzinski ,  Mr. Amo ,  Mr. Davis of Illinois ,  Mr. Thanedar ,  Mr. Goldman of New York ,  Mrs. McClain Delaney ,  Mr. Carson ,  Ms. Norton , and  Mrs. Grijalva ) introduced the following bill; which was referred to the  Committee on Education and Workforce    A BILL
To require the Secretary of Labor to issue guidance and regulations regarding opioid overdose reversal medication and employee training.
1.
Short title
This Act may be cited as the   Workplace Overdose Reversal Kits to Save Lives Act   or the   WORK to Save Lives Act  .
2.
Non-mandatory guidance for employers concerning opioid overdose reversal medication
(a)
In general
Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue nonmandatory guidance to employers on—
(1)
acquiring and maintaining opioid overdose reversal medication; and
(2)
offering voluntary training to employees on an annual basis on the usage of such medication.
(b)
Employer defined
In this section, the term  employer  has the meaning given such term in section 3 of the Occupational Safety and Health Act of 1970 ( 29 U.S.C. 652 ), except that such term does not include the United States Postal Service.
3.
Mandatory regulations for Federal agencies concerning opioid overdose reversal medication
(a)
In general
Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue regulations to require each Federal agency to—
(1)
acquire and maintain opioid overdose reversal medication; and
(2)
offering voluntary training to employees on an annual basis on the usage of such medication.
(b)
Federal agency defined
In this section, the term  Federal agency  means any agency or instrumentality of the Federal Government, including the Veterans Health Administration, notwithstanding section 7425(b) of title 38, United States Code.